Replimune Group
REPL
REPL
161 hedge funds and large institutions have $348M invested in Replimune Group in 2025 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 61 increasing their positions, 47 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 49
54% less capital invested
Capital invested by funds: $752M → $348M (-$405M)
86% less funds holding in top 10
Funds holding in top 10: 7 → 1 (-6)
Holders
161
Holding in Top 10
1
Calls
$41.2M
Puts
$13.4M
Top Buyers
| 1 | +$18.1M | |
| 2 | +$12.2M | |
| 3 | +$10.2M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$9.75M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$9.2M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$17.3M | |
| 3 | -$16.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.5M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$9.14M |
